病理缓解转化为肝细胞癌局部区域治疗后的生存改善:微创微波消融的重要性
MIS-MWA和联合组总生存优于TACE(p=0.017)。
要点
- MIS-MWA的完全病理坏死率显著高于TACE或联合治疗。
- MIS-MWA和MIS-MWA-TACE的总生存优于TACE。
- CT评估MIS-MWA疗效的敏感性仅50%,需谨慎解读。
核心结论
- MIS-MWA单独或联合TACE对肿瘤活性的影响优于单独TACE,可能改善总生存。
主要发现
- 残留存活肿瘤比例:MIS-MWA组17.2%,TACE组48.7%,MIS-MWA-TACE组18.6%(p≤0.0001)。
- 总生存:MIS-MWA组99.94个月,TACE组75.35个月,MIS-MWA-TACE组140个月(p=0.017)。
- 按肿瘤大小分层后生存差异仍有统计学意义。
- CT诊断准确性:MIS-MWA敏感性50%、特异性86%;TACE敏感性82%、特异性33%;MIS-MWA-TACE敏感性42%、特异性78%。
临床怎么用
- 对于拟行肝切除或肝移植的HCC患者,可优先考虑MIS-MWA或MIS-MWA-TACE以增加病理完全坏死机会。
- 解读MIS-MWA后的CT疗效时需注意其敏感性较低,避免假阴性误导治疗决策。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hepatectomy or transplantation can serve as curative treatment for early-stage hepatocellular carcinoma (HCC). Unfortunately, as progression remains a reality, locoregional therapies (LRT) for curative or bridging intent have become common. Efficacy on viability, outcomes, and accuracy of imaging should be defined to guide treatment. METHODS: Patients with HCC who underwent minimally invasive (MIS) microwave ablation (MWA), transarterial chemoembolization (TACE), or both (MIS-MWA-TACE) prior to hepatectomy or transplantation were identified. Tumor response and preoperative computed tomography (CT) accuracy were assessed and compared to pathology. Clinical and oncologic outcomes were compared between MIS-MWA, TACE, and MIS-MWA-TACE. RESULTS: Ninety-one patients, with tumors from all stages of the Barcelona Clinic Liver Cancer (BCLC) staging, were identified who underwent LRT prior to resection or transplant. Fourteen patients underwent MIS-MWA, 46 underwent TACE, and 31 underwent both neoadjuvantly. TACE population was older; otherwise, there were no differences in demographics. Fifty-seven percent of MIS-MWA patients had no viable tumor on pathology whereas only 13% of TACE patients and 29% of MIS-MWA-TACE patients had complete destruction (p = 0.004). The amount of remaining viable tumor in the explant was also significantly different between groups (MIS-MWA: 17.2%, TACE: 48.7%, MIS-MWA-TACE: 18.6%; p ≤ 0.0001). Compared with TACE, the MIS-MWA and MIS-MWA-TACE groups had significantly improved overall survival (MIS-MWA: 99.94 months, TACE: 75.35 months, MIS-MWA-TACE: 140 months; p = 0.017). This survival remained significant with stratification by tumor size. CT accuracy was found to be 50% sensitive and 86% specific for MIS-MWA. For TACE, CT had an 82% sensitivity and 33% specificity and for MIS-MWA-TACE, there was a 42% sensitivity and 78% specificity. CONCLUSION: The impact of locoregional treatments on tumor viability is distinct and superior with MIS-MWA alone and MIS-MWA-TACE offering significant advantage over TACE alone. The extent of this effect may be implicated in the improved overall survival.
引用
- Baimas-George M, Watson M, Sulzer J, et al. Pathologic response translates to improved patient survival after locoregional treatment for hepatocellular carcinoma: the importance of minimally invasive microwave ablation. Surg Endosc. 2020. PMID: 32588344. doi:10.1007/s00464-020-07747-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。